Mon Sep 23 15:11:14 UTC 2024: ## MultiPlan Stock Hits New 52-Week Low Amidst Insider Buying and Analyst Downgrade
**New York, NY (MarketBeat News) -** MultiPlan Co. (NYSE: MPLN) shares plunged to a new 52-week low on Monday, reaching $6.36 during mid-day trading. The stock closed at $7.89, a significant drop from its previous close of $7.52. This downturn comes amidst a series of recent events, including a downgraded price target by Piper Sandler and insider buying activity.
Piper Sandler analysts reiterated a “neutral” rating on MultiPlan shares, while lowering their price target from $2.00 to $1.00. This move reflects the firm’s cautious outlook on the company’s future prospects.
Despite the stock’s downward trend, there has been significant insider buying activity. CFO Douglas Michael Garis purchased 1,150,000 shares at an average price of $0.30, while SVP William B. Mintz acquired 81,165 shares at an average price of $0.31. These purchases, disclosed in SEC filings, suggest confidence in the company’s long-term potential despite the recent market challenges.
MultiPlan’s earnings report, released on August 1st, showed a net loss of $0.03 per share, beating analyst expectations of a $0.04 loss. However, revenue came in lower than anticipated, reaching $233.48 million compared to the consensus estimate of $253.59 million.
While MultiPlan’s recent performance has been mixed, insider buying activity and the company’s focus on data analytics and cost management solutions for the healthcare industry may provide some optimism for future growth.
**About MultiPlan:**
MultiPlan Corporation provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
First Piper 